Bristol Myers Squibb plans another major round of job cuts in New Jersey, bringing the number of total layoffs the company ...

Par Health has issued a voluntary recall of two lots of the IV sedative dexmedetomidine HCl in 0.9% sodium chloride injection ...

AI is a theme on the mind of every pharma marketer these days as the evolving technology continues to hold an increasingly important role in the field. | Genentech's chief marketing officer Zoë ...

As China and the U.S. presently duke it out over biopharma innovation supremacy, a clutch of Europe’s biggest drugmakers are calling on the bloc to not lose sight of its R&D roots. | As China and the ...

Eric Dube, Ph.D., the CEO who rebranded Travere Therapeutics and oversaw the launch of its rare kidney disease drug Filspari, will ...

The White House is threatening yet another change to the childhood vaccine schedule in line with Secretary of Health and Human Services secretary Robert F. Kennedy Jr.’s MAHA agenda.  | The president ...

Bayer has decided to offload its aging cancer drug Stivarga to German compatriot Grünenthal as competition mounts. | Bayer has decided to offload its aging cancer drug Stivarga to German compatriot ...

"These Phase 3 results build on the established efficacy of Caplyta in bipolar depression and represent an important step in evaluating its potential to address both depressive and acute manic ...

Eli Lilly is sharpening its competitive edge in the crowded oral SERD arena as the FDA has approved a combination of its ...

AI is already changing how pharma marketers work, from summarizing research to analyzing campaign performance and identify ...

Novo CEO Mike Doustdar faced a tough crowd as the Danish pharma gathered investors in London this morning for the compan | With reports leaking out of investor discontent, CEO Mike Doustdar opened ...

Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to ...